Skip to content

Efficacy trial of single intake of plant derived ingredient on glucose metabolism. [n2017006]

Efficacy trial of single intake of plant derived ingredient on glucose metabolism. [n2017006] - Efficacy of plant derived ingredient [n2017006]

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000047544
Enrollment
20
Registered
2022-04-28
Start date
2017-10-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Sponsors

Kao Corporation
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1)Healthy men (2)Adult aged from 20 y to 60 y (3)The person who can participate on the scheduled day (4)The person who have given written informed consent prior to the study (5)The person who can consume test foods (6)The person who con record habitual lifestyle and diets

Exclusion criteria

Exclusion criteria: (1) Diabetes mellitus (2) Having history or presence of cardiovascular disease or cerebrovascular disease (3) Presence of liver, kidney or respiratory disease, endocrine disorder, metabolic disorder, organ disorder, gout, rheumatism, autoimmune disease, allergy disease, mental disorder, cancer, infection disease, or other diseases (4) Having history of resection of gastrointestinal tract (5) Thyroid deficiency (6) Smoker (7) Heavy alcohol drinker (over 30g per day) (8) Donated over 200 mL of blood within the last one month prior to the study or over 400 mL of blood within the last three months prior to the study (9) Severe anemia (Hb <=7g/dL) (10) Feeling sick due to blood collection (11) Food allergies for test meals (12) Food allergies for test foods (13) Cannot take all of the test food (14) Planned to participate in other clinical study during current study (15) Determined to be unqualified by the physician in charge or the responsible person of the study

Design outcomes

Primary

MeasureTime frame
Blood incretin concentration

Countries

Japan

Contacts

Public ContactAya Yanagimoto

Kao Corporation Biological Science Reseach Laboratories

yanagimoto.aya@kao.com03-5630-7476

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026